Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

计划入组 58 人 · 首次发布于 2022 年 6 月 24 日

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

计划入组 62 人 · 首次发布于 2022 年 3 月 24 日

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

计划入组 30 人 · 首次发布于 2023 年 7 月 7 日

Aceclidine

C₉H₁₅NO₂

Aceclidine/Tropicamide

Phenyramydol HCl

HighCom Ltd

United Kingdom

HCG HOSPITALS

India

HCW Biologics

United States

Lenz Therapeutics' LNZ100 Demonstrates Positive Phase 3 Results for Presbyopia in China

LNZ100 Demonstrates Positive Phase 3 Results for Presbyopia Treatment in China

Lenz Therapeutics' LNZ100 Demonstrates Positive Phase 3 Results in China for Presbyopia